Optimistic Buy Rating: Strong Phase 2 Results and Regulatory Progress for Verastem's Avutometinib and Defactinib

TipRanksOct 21 20:48 · Ratings

Cantor Fitzgerald Reiterates Overweight on Verastem

BenzingaOct 18 19:58

Verastem (VSTM) Receives a Buy From RBC Capital

TipRanksOct 18 19:26 · Ratings

H.C. Wainwright Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $7

Futu NewsOct 18 18:31 · Ratings

Truist Financial Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $15

Futu NewsOct 18 02:32 · Ratings

Verastem Stock: Buy Rating Amid Market Overreaction and Promising Commercial Potential

TipRanksOct 18 02:05 · Ratings